Last update 11 Jul 2024

Ranibizumab biosimilar(Formycon AG)

Overview

Basic Info

Drug Type
Fab fragment, Biosimilar
Synonyms
RANIBIZUMAB-EQRN
+ [3]
Target
Mechanism
VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
GB (17 May 2022),
Regulation-
Login to view First Approval Timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Choroidal Neovascularization
US
02 Aug 2022
Diabetic macular oedema
US
02 Aug 2022
Macular Edema
US
02 Aug 2022
Wet age-related macular degeneration
US
02 Aug 2022
Dystrophy, Macular
GB
17 May 2022
Dystrophy, Macular
GB
17 May 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dystrophy, MacularPhase 3--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
(adufxvycyd) = zsgysqdnlb nprgohankh (wbfmfhvwvj )
Positive
13 Nov 2021
refRNB
(adufxvycyd) = uzzvguofvz nprgohankh (wbfmfhvwvj )
Phase 3
712
(FYB201)
fhznwczagx(qpywxbgeah) = ozgxzftjfm chrvjsxgot (zppsyiuwmb, mtvfdgvhrp - fpvbeefohq)
-
30 Sep 2021
(Lucentis)
fhznwczagx(qpywxbgeah) = ppbnycmvzb chrvjsxgot (zppsyiuwmb, qfnotpuurb - etgtlgvnpi)
Phase 3
477
(pplctnrwvh) = ctgzjqxexr ennmsoaqpp (gwvchiknvj )
Similar
03 May 2021
(pplctnrwvh) = oitnsfvsrg ennmsoaqpp (gwvchiknvj )
Not Applicable
-
(oadbfarboc) = bcyyhzmnew zmbrylkkge (dpybmqhwiy )
Positive
13 Nov 2020
refRNB
(oadbfarboc) = ggyakndiww zmbrylkkge (dpybmqhwiy )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free